Messina: a novel analysis tool to identify biologically relevant molecules in disease.

<h4>Background</h4>Morphologically similar cancers display heterogeneous patterns of molecular aberrations and follow substantially different clinical courses. This diversity has become the basis for the definition of molecular phenotypes, with significant implications for therapy. Micro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Mark Pinese, Christopher J Scarlett, James G Kench, Emily K Colvin, Davendra Segara, Susan M Henshall, Robert L Sutherland, Andrew V Biankin
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2009
Materias:
R
Q
Acceso en línea:https://doaj.org/article/01e2c7a2eb7b4b7889d9efa18d1276d6
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:01e2c7a2eb7b4b7889d9efa18d1276d6
record_format dspace
spelling oai:doaj.org-article:01e2c7a2eb7b4b7889d9efa18d1276d62021-11-25T06:22:59ZMessina: a novel analysis tool to identify biologically relevant molecules in disease.1932-620310.1371/journal.pone.0005337https://doaj.org/article/01e2c7a2eb7b4b7889d9efa18d1276d62009-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/19399185/?tool=EBIhttps://doaj.org/toc/1932-6203<h4>Background</h4>Morphologically similar cancers display heterogeneous patterns of molecular aberrations and follow substantially different clinical courses. This diversity has become the basis for the definition of molecular phenotypes, with significant implications for therapy. Microarray or proteomic expression profiling is conventionally employed to identify disease-associated genes, however, traditional approaches for the analysis of profiling experiments may miss molecular aberrations which define biologically relevant subtypes.<h4>Methodology/principal findings</h4>Here we present Messina, a method that can identify those genes that only sometimes show aberrant expression in cancer. We demonstrate with simulated data that Messina is highly sensitive and specific when used to identify genes which are aberrantly expressed in only a proportion of cancers, and compare Messina to contemporary analysis techniques. We illustrate Messina by using it to detect the aberrant expression of a gene that may play an important role in pancreatic cancer.<h4>Conclusions/significance</h4>Messina allows the detection of genes with profiles typical of markers of molecular subtype, and complements existing methods to assist the identification of such markers. Messina is applicable to any global expression profiling data, and to allow its easy application has been packaged into a freely-available stand-alone software package.Mark PineseChristopher J ScarlettJames G KenchEmily K ColvinDavendra SegaraSusan M HenshallRobert L SutherlandAndrew V BiankinPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 4, Iss 4, p e5337 (2009)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Mark Pinese
Christopher J Scarlett
James G Kench
Emily K Colvin
Davendra Segara
Susan M Henshall
Robert L Sutherland
Andrew V Biankin
Messina: a novel analysis tool to identify biologically relevant molecules in disease.
description <h4>Background</h4>Morphologically similar cancers display heterogeneous patterns of molecular aberrations and follow substantially different clinical courses. This diversity has become the basis for the definition of molecular phenotypes, with significant implications for therapy. Microarray or proteomic expression profiling is conventionally employed to identify disease-associated genes, however, traditional approaches for the analysis of profiling experiments may miss molecular aberrations which define biologically relevant subtypes.<h4>Methodology/principal findings</h4>Here we present Messina, a method that can identify those genes that only sometimes show aberrant expression in cancer. We demonstrate with simulated data that Messina is highly sensitive and specific when used to identify genes which are aberrantly expressed in only a proportion of cancers, and compare Messina to contemporary analysis techniques. We illustrate Messina by using it to detect the aberrant expression of a gene that may play an important role in pancreatic cancer.<h4>Conclusions/significance</h4>Messina allows the detection of genes with profiles typical of markers of molecular subtype, and complements existing methods to assist the identification of such markers. Messina is applicable to any global expression profiling data, and to allow its easy application has been packaged into a freely-available stand-alone software package.
format article
author Mark Pinese
Christopher J Scarlett
James G Kench
Emily K Colvin
Davendra Segara
Susan M Henshall
Robert L Sutherland
Andrew V Biankin
author_facet Mark Pinese
Christopher J Scarlett
James G Kench
Emily K Colvin
Davendra Segara
Susan M Henshall
Robert L Sutherland
Andrew V Biankin
author_sort Mark Pinese
title Messina: a novel analysis tool to identify biologically relevant molecules in disease.
title_short Messina: a novel analysis tool to identify biologically relevant molecules in disease.
title_full Messina: a novel analysis tool to identify biologically relevant molecules in disease.
title_fullStr Messina: a novel analysis tool to identify biologically relevant molecules in disease.
title_full_unstemmed Messina: a novel analysis tool to identify biologically relevant molecules in disease.
title_sort messina: a novel analysis tool to identify biologically relevant molecules in disease.
publisher Public Library of Science (PLoS)
publishDate 2009
url https://doaj.org/article/01e2c7a2eb7b4b7889d9efa18d1276d6
work_keys_str_mv AT markpinese messinaanovelanalysistooltoidentifybiologicallyrelevantmoleculesindisease
AT christopherjscarlett messinaanovelanalysistooltoidentifybiologicallyrelevantmoleculesindisease
AT jamesgkench messinaanovelanalysistooltoidentifybiologicallyrelevantmoleculesindisease
AT emilykcolvin messinaanovelanalysistooltoidentifybiologicallyrelevantmoleculesindisease
AT davendrasegara messinaanovelanalysistooltoidentifybiologicallyrelevantmoleculesindisease
AT susanmhenshall messinaanovelanalysistooltoidentifybiologicallyrelevantmoleculesindisease
AT robertlsutherland messinaanovelanalysistooltoidentifybiologicallyrelevantmoleculesindisease
AT andrewvbiankin messinaanovelanalysistooltoidentifybiologicallyrelevantmoleculesindisease
_version_ 1718413782097592320